EUCTR2006-006203-36-NL进行中（未招募）不适用
Dopaminergic neurotransmission and cognitive decline in velocardiofacial syndrome - Dementia in VCFS
Academic Medical Centre (AMC)0 个研究点开始时间: 2008年6月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •40 patients with VCFS age 18 and older and an IQ below 55. Of these twenty will have a premorbid functioning without a cognitive decline and twenty will have a higher premorbid functioning with a cognitive decline
- •20 healthy volunteers and 20 patients with VCFS and no psychosis and cognitive decline. The last group (20 healthy and 20 VCFS patients with no psychoses) have been investigated in another study (MEC 04/200) and will be used as controles in our group.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Dopaminergic neurotransmission and cognitive deterioration in velocardiofacial syndromeNL-OMON33641Medisch Universitair Ziekenhuis Maastricht44
撤回
不适用
Dopaminergic neurotransmission and cognitive decline in velocardiofacial syndromedementiacognitive decline10083624NL-OMON31666Academisch Medisch Centrum40
尚未招募
不适用
Het dopamine systeem en cognitieve achteruitgang bij patiënten met VCFS.velocardiofacial syndromedel22q11.2dementiadementievelocardiofaciaal syndroomNL-OMON26307Governor Kremers Centre / Department of Clinical GeneticsMaastricht, the Netherlands44
招募中
不适用
Dopaminergic modulation of cognition and psychomotor functiogeen aandoeningNL-OMON38372niversiteit Maastricht30
进行中（未招募）
不适用
Modulación dopaminérgica de las funciones cognitivas y afectivas por el tratamiento con diferentes métodos de estimulación dopaminérgica en la enfermedad de Parkinson . Implicaciones para el tratamiento con levodopa.Fluctuaciones motoras, cognitivas y del humor en la enfermedad de Parkinson.MedDRA version: 8.1Level: PTClassification code 10061536Term: Parkinson's diseaseEUCTR2006-002408-32-ESInstitut de Recerca del Hospital de la Santa Creu i Sant Pau20